Effect of apolipoprotein C1 expression on proliferation and apoptosis of human liver cancer HepG2 cells and its mechanism

Huijuan SONG,Zhenhua XU,Dongning HE

PDF(1395 KB)
PDF(1395 KB)
J Jilin Univ Med Ed ›› 2024, Vol. 50 ›› Issue (1) : 128-135. DOI: 10.13481/j.1671-587X.20240116
Research in basic medicine

Effect of apolipoprotein C1 expression on proliferation and apoptosis of human liver cancer HepG2 cells and its mechanism

  • Huijuan SONG1,Zhenhua XU2,Dongning HE3()
Author information +
History +

Abstract

Objective To discuss the effect of apolipoprotein C1 (APOC1) expression on the proliferation and apoptosis of the hepatocellular carcinoma cells, and to preliminarily clarify the related molecular mechanism. Methods The expression level of APOC1 mRNA in hepatocellular carcinoma tissue and its relationship with the prognosis of the patient were analyzed by The Cancer Genome Atlas (TCGA) Database; real-time fluorescence quantitative PCR (RT-qPCR) method was used to detect the expression levels of APOC1 mRNA in different hepatocellular carcinoma cells; the human liver cancer HepG2 cells with low APOC1 expression were selected as the subjects. The HepG2 cells were transfected with pcDNA3.1-APOC1 plasmid to over-express APOC1 (APOC1 over-expression group),and the HepG2 cells transfected with empty vector pcDNA3.1 were regarded as control group. MTS assay and 5-ethynyl-2'-deoxyuridine (EdU) staining were used to detect the proliferative activities and proliferation rates of the cells in two groups; Transwell chamber assay was used to detect the numbers of migration cells in two groups;flow cytometry and TUNEL assay were used to detect the percentages of the cells at different cell cycles and apoptotic rates in two groups;Western blotting method was used to detect the expression levels of extracellular regulated protein kinase (ERK), phosphorylated ERK (p-ERK), protein kinase B (AKT), phosphorylated AKT (p-AKT), B-cell lymphoma-2 (Bcl-2), and cleaved cysteinyl aspartate specific proteinase-3(cleaved caspase-3) proteins in the cells in two groups. Results The TCGA Database results showed that the expression level of APOC1 mRNA in hepatocellular carcinoma tissue was lower than that in normal liver tissue (P<0.05), and the patients with low expression of APOC1 mRNA had poor prognosis. The RT-qPCR results showed that the expression level of APOC1 mRNA in the HepG2 cells was the lowest, and the HepG2 cells were chosen for the subsequent research. Compared with control group, the proliferative activity and proliferation rate of the cells in APOC1 over-expression group were decreased (P<0.05 or P<0.01),the number of migration cells was decreased (P<0.01),and the percentage of the cells at S phase and the apoptotic rate were significantly increased (P<0.01). Compared with control group, the expression levels of p-ERK, p-AKT, and Bcl-2 proteins in the cells in APOC1 over-expression group were significantly decreased (P<0.05),and the expression level of cleaved caspase-3 protein was increased (P<0.01). Conclusion High expression of APOC1 can inhibit the proliferation of the human liver cancer HepG2 cells and induce the apoptosis,and its mechanism may be related to inhibition of the expressions of p-ERK,p-AKT,Bcl-2 proteins and promotion of the expression of cleaved caspase-3 protein.

Key words

Apolipoprotein C1 / Liver neoplasm / Cell proliferation / Apoptosis / Human liver cancer HepG2 cell

CLC number

R735.7

Cite this article

Download Citations
Huijuan SONG,Zhenhua XU,Dongning HE. Effect of apolipoprotein C1 expression on proliferation and apoptosis of human liver cancer HepG2 cells and its mechanism. Journal of Jilin University(Medicine Edition). 2024, 50(1): 128-135 https://doi.org/10.13481/j.1671-587X.20240116

References

1 韩家鑫, 宓余强, 徐 亮, 等. 肝细胞癌早期筛查和诊断的研究进展[J]. 临床肝胆病杂志. 2023,39(6): 1468-1475.
2 SONG H J, SUN N, LIN L, et al. Splicing factor PRPF6 upregulates oncogenic androgen receptor signaling pathway in hepatocellular carcinoma[J]. Cancer Sci, 2020, 111(10): 3665-3678.
3 SU W P, SUN L N, YANG S L,et al.Apolipoprotein C1 promotes prostate cancer cell proliferation in vitro [J]. J Biochem Mol Toxicol, 2018, 32(7): e22158.
4 YI J, REN L W, WU J, et al. Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for gastric cancer[J]. Ann Transl Med, 2019, 7(16): 380.
5 徐胜元, 毕林刚, 于志勇. 载脂蛋白C1在胃癌患者中的表达及其与预后的关系[J]. 重庆医学, 2020, 49(23): 3974-3978.
6 GUO Q, LIU X L, JIANG N, et al. Decreased APOC1 expression inhibited cancer progression and was associated with better prognosis and immune microenvironment in esophageal cancer[J]. Am J Cancer Res, 2022, 12(11): 4904-4929.
7 CAO X Y, WU B Q, GUO S M, et al. APOC1 predicts a worse prognosis for esophageal squamous cell carcinoma and is associated with tumor immune infiltration during tumorigenesis[J]. Pathol Oncol Res, 2023, 29: 1610976.
8 ENGWEGEN J Y, DEPLA A C, SMITS M E, et al. Detection of colorectal cancer by serum and tissue protein profiling: a prospective study in a population at risk[J]. Biomark Insights, 2008, 3: 375-385.
9 FAN Y X, SHI L N, LIU Q L, et al. Discovery and identification of potential biomarkers of papillary thyroid carcinoma[J]. Mol Cancer, 2009, 8: 79.
10 ZHANG Q, WANG J X, DONG R, et al. Identification of novel serum biomarkers in child nephroblastoma using proteomics technology[J]. Mol Biol Rep, 2011, 38(1): 631-638.
11 LIU J F, LICHTENBERG T, HOADLEY K A, et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics[J]. Cell, 2018, 173(2): 400-416.
12 TANG W W, LIU H Y, LI X, et al. Upregulation of APOC1 promotes colorectal cancer progression and serves as a potential therapeutic target based on bioinformatics analysis[J]. J Oncol, 2023, 2023: 2611105.
13 MA X L, GAO X H, GONG Z J, et al. Apolipoprotein A1: a novel serum biomarker for predicting the prognosis of hepatocellular carcinoma after curative resection[J]. Oncotarget, 2016, 7(43): 70654-70668.
14 JAYAKAR S K, LOUDIG O, BRANDWEIN-GENSLER M, et al. Apolipoprotein E promotes invasion in oral squamous cell carcinoma[J]. Am J Pathol, 2017, 187(10): 2259-2272.
15 张艺博, 姚 霜, 程港丽, 等. 载脂蛋白M对肾癌细胞增殖、迁移与侵袭的抑制作用[J]. 临床与病理杂志, 2021, 41(6): 1227-1236.
16 杨凤鸣, 李 聪, 冒学莲, 等. 肺癌患者血清载脂蛋白C1水平及临床意义[J]. 国际检验医学杂志, 2021, 42(23): 2839-2843.
17 CARGNELLO M, ROUX P P. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases[J]. Microbiol Mol Biol Rev, 2011, 75(1): 50-83.
18 JOHNSON G L, LAPADAT R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases[J]. Science, 2002, 298(5600): 1911-1912.
19 孔雯聪, 贺武斌, 苏荣健, 等. MST1R抑制剂BMS-777607对乳腺癌MCF-7细胞增殖的抑制和凋亡诱导作用[J]. 吉林大学学报(医学版), 2020, 46(3): 451-457.
20 田 乐, 王颖航, 潘 志, 等. 基于网络药理学探讨消癥活络方通过ERK5通路抗大鼠肝纤维化的机制[J]. 临床肝胆病杂志, 2021,37(3): 582-589.
21 CHEN J H, CHIANG I T, HSU F T. Protein kinase B inactivation is associated with magnolol-enhanced therapeutic efficacy of sorafenib in hepatocellular carcinoma in vitro and in vivo [J].Cancers,2019,12(1): 87.
22 HUA H, ZHU Y, SONG Y H. Ruscogenin suppressed the hepatocellular carcinoma metastasis via PI3K/Akt/mTOR signaling pathway[J]. Biomed Pharmacother, 2018, 101: 115-122.

Comments

PDF(1395 KB)

Accesses

Citation

Detail

Sections
Recommended

/